Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Orkin

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
BMJ Leader|May 18, 2023
Reflections and intersections: disability, 'ableism' and metamodern leadershipChloe Orkin
Open Forum Infectious Diseases|February 14, 2024
Should Human Immunodeficiency Virus Testing Be Replaced With Combined Blood-Borne Virus Testing?Chloe Orkin
The Lancet. HIV|June 17, 2019
Does less equal more yet?Chloe Orkin
The Lancet. HIV|December 24, 2022
Lenacapavir in first-line therapyChloe Orkin
Current Opinion in Infectious Diseases|December 18, 2020
Long-acting injectable HIV therapies: the next frontierJohn Thornhill, Chloe Orkin
The Lancet. HIV|November 29, 2015
Should HIV testing week be blood-borne-virus testing week?Chloe Orkin, Emma Wallis
Current Opinion in HIV and AIDS|February 24, 2021
Long-acting injectable HIV therapies: the next frontier: RepublicationJohn Thornhill, Chloe Orkin
Expert Opinion on Investigational Drugs|November 19, 2019
Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agentsMuge Cevik, Chloe Orkin
HIV Medicine|July 18, 2025
Editorial comment on: Gender equality in leadership of HIV care cascade clinical trials: A methodological studyChloé Pasin, Chloe Orkin
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 16, 2023
Changing face of mpoxMuge Cevik, Chloe Orkin
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
BMJ Leader|May 18, 2023
Reflections and intersections: disability, 'ableism' and metamodern leadershipChloe Orkin
Open Forum Infectious Diseases|February 14, 2024
Should Human Immunodeficiency Virus Testing Be Replaced With Combined Blood-Borne Virus Testing?Chloe Orkin
The Lancet. HIV|June 17, 2019
Does less equal more yet?Chloe Orkin
The Lancet. HIV|December 24, 2022
Lenacapavir in first-line therapyChloe Orkin
Current Opinion in Infectious Diseases|December 18, 2020
Long-acting injectable HIV therapies: the next frontierJohn Thornhill, Chloe Orkin
The Lancet. HIV|November 29, 2015
Should HIV testing week be blood-borne-virus testing week?Chloe Orkin, Emma Wallis
Current Opinion in HIV and AIDS|February 24, 2021
Long-acting injectable HIV therapies: the next frontier: RepublicationJohn Thornhill, Chloe Orkin
Expert Opinion on Investigational Drugs|November 19, 2019
Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agentsMuge Cevik, Chloe Orkin
HIV Medicine|July 18, 2025
Editorial comment on: Gender equality in leadership of HIV care cascade clinical trials: A methodological studyChloé Pasin, Chloe Orkin
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 16, 2023
Changing face of mpoxMuge Cevik, Chloe Orkin
Pageof 19